DYN - SEC Form 4 insider transactions

SEC Form 4 filed by Director Hurwitz Edward

SEC Form 4 filed by Director Lubner David Charles

SEC Form 4 filed by Director Rhodes Jason P

SEC Form 4 filed by Director Kersten Dirk

SEC Form 4 filed by Director Incerti Carlo

SEC Form 4 filed by Director Stehman-Breen Catherine

Chief Commercial Officer Friedl-Naderer Johanna sold $4,186 worth of shares (228 units at $18.36) as part of a pre-agreed trading plan, decreasing direct ownership by 0.15% to 154,353 units (SEC Form 4) to cover withholding tax

Chief Medical Officer Kerr Douglas sold $28,715 worth of shares (1,564 units at $18.36) as part of a pre-agreed trading plan, decreasing direct ownership by 0.91% to 170,042 units (SEC Form 4) to satisfy withholding obligation

Chief Financial Officer Lucera Erick sold $26,585 worth of shares (1,448 units at $18.36) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 123,925 units (SEC Form 4) to cover taxes

CEO & President Cox John sold $60,790 worth of shares (3,311 units at $18.36) as part of a pre-agreed trading plan, decreasing direct ownership by 0.88% to 370,834 units (SEC Form 4) (withholding obligation)

Director Rhodes Jason P sold $1,936,341 worth of shares (106,723 units at $18.14) as part of a pre-agreed trading plan (SEC Form 4)

Director Rhodes Jason P sold $4,178,516 worth of shares (227,337 units at $18.38) as part of a pre-agreed trading plan (SEC Form 4)

Director Lubner David Charles gifted 53,625 shares, closing all direct ownership in the company (SEC Form 4)

Director Rhodes Jason P sold $7,101,120 worth of shares (384,549 units at $18.47) as part of a pre-agreed trading plan (SEC Form 4)

Director Kersten Dirk sold $219,170 worth of shares (10,952 units at $20.01) as part of a pre-agreed trading plan (SEC Form 4)

SEC Form 4 filed by Rhodes Jason P

SEC Form 4 filed by Kersten Dirk

SEC Form 4 filed by Kersten Dirk

SEC Form 4 filed by Lucera Erick

SEC Form 4 filed by Posner Brian S

Director Kersten Dirk sold $2,530,562 worth of shares (129,672 units at $19.52) (SEC Form 4)

Director Kersten Dirk sold $13,149,314 worth of shares (688,788 units at $19.09) (SEC Form 4)

Chief Commercial Officer Friedl-Naderer Johanna sold $2,205 worth of shares (148 units at $14.90), decreasing direct ownership by 0.10% to 154,581 units (SEC Form 4)

Chief Medical Officer Kerr Douglas sold $13,470 worth of shares (904 units at $14.90), decreasing direct ownership by 0.52% to 171,606 units (SEC Form 4)

CEO & President Cox John sold $40,707 worth of shares (2,732 units at $14.90), decreasing direct ownership by 0.72% to 374,145 units (SEC Form 4)

CEO & President Cox John was granted 180,000 shares, increasing direct ownership by 91% to 376,877 units (SEC Form 4)

Chief Medical Officer Kerr Douglas was granted 85,000 shares, increasing direct ownership by 97% to 172,510 units (SEC Form 4)

Chief Commercial Officer Friedl-Naderer Johanna was granted 60,000 shares, increasing direct ownership by 63% to 154,729 units (SEC Form 4)

Chief Financial Officer Lucera Erick was granted 65,000 shares, increasing direct ownership by 98% to 131,100 units (SEC Form 4)

SEC Form 4 filed by Director Karnani Vikram

CEO & President Cox John sold $55,157 worth of shares (2,662 units at $20.72), decreasing direct ownership by 1% to 196,877 units (SEC Form 4)

Chief Medical Officer Kerr Douglas sold $18,234 worth of shares (880 units at $20.72), decreasing direct ownership by 1.00% to 87,510 units (SEC Form 4)

Chief Commercial Officer Friedl-Naderer Johanna sold $2,984 worth of shares (144 units at $20.72), decreasing direct ownership by 0.15% to 94,729 units (SEC Form 4)

SEC Form 4 filed by Director Posner Brian S

CEO & President Cox John sold $35,402 worth of shares (2,640 units at $13.41), decreasing direct ownership by 1% to 199,539 units (SEC Form 4)

Chief Commercial Officer Friedl-Naderer Johanna sold $13,794 worth of shares (1,038 units at $13.29), decreasing direct ownership by 1% to 94,873 units (SEC Form 4)

Chief Medical Officer Kerr Douglas sold $58,842 worth of shares (4,425 units at $13.30), decreasing direct ownership by 5% to 88,390 units (SEC Form 4)

SEC Form 4 filed by Chief Commercial Officer Friedl-Naderer Johanna

SEC Form 4 filed by Chief Medical Officer Kerr Douglas

SEC Form 4 filed by CEO & President Cox John

CEO & President Cox John sold $54,201 worth of shares (4,060 units at $13.35), decreasing direct ownership by 3% to 142,179 units (SEC Form 4)

Chief Medical Officer Kerr Douglas sold $17,916 worth of shares (1,342 units at $13.35), decreasing direct ownership by 1% to 92,815 units (SEC Form 4)

Chief Commercial Officer Friedl-Naderer Johanna sold $1,949 worth of shares (146 units at $13.35), decreasing direct ownership by 0.15% to 95,911 units (SEC Form 4)

SEC Form 4 filed by Director Hurwitz Edward

SEC Form 4 filed by Director Lubner David Charles

SEC Form 4 filed by Director Rhodes Jason P

SEC Form 4 filed by Director Kersten Dirk

SEC Form 4 filed by Director Incerti Carlo

SEC Form 4 filed by Director Stehman-Breen Catherine

Chief Financial Officer Lucera Erick was granted 66,100 shares (SEC Form 4)

Chief Commercial Officer Friedl-Naderer Johanna sold $1,733 worth of shares (143 units at $12.12), decreasing direct ownership by 0.15% to 96,057 units (SEC Form 4)

SVP, Head of Finance & Admin. Scalzo Richard William sold $15,283 worth of shares (1,343 units at $11.38), decreasing direct ownership by 1% to 122,330 units (SEC Form 4)

Chief Scientific Officer Beskrovnaya Oxana sold $24,501 worth of shares (2,153 units at $11.38), decreasing direct ownership by 1% to 195,840 units (SEC Form 4)

Chief Medical Officer Kerr Douglas sold $15,888 worth of shares (1,343 units at $11.83), decreasing direct ownership by 1% to 94,157 units (SEC Form 4)

CEO & President Cox John sold $48,042 worth of shares (4,061 units at $11.83), decreasing direct ownership by 3% to 146,239 units (SEC Form 4)

SVP, Head of Finance & Admin. Scalzo Richard William sold $10,848 worth of shares (917 units at $11.83), decreasing direct ownership by 0.74% to 123,673 units (SEC Form 4)

Chief Scientific Officer Beskrovnaya Oxana sold $12,942 worth of shares (1,094 units at $11.83), decreasing direct ownership by 0.55% to 197,993 units (SEC Form 4)

Chief Scientific Officer Beskrovnaya Oxana sold $36,242 worth of shares (2,598 units at $13.95), decreasing direct ownership by 1% to 199,087 units (SEC Form 4)

SVP, Head of Finance & Admin. Scalzo Richard William sold $34,708 worth of shares (2,488 units at $13.95), decreasing direct ownership by 2% to 124,590 units (SEC Form 4)

Director Rhodes Jason P was granted 1,111,111 shares (SEC Form 4)